多克索鲁比改变了大鼠冠状动脉中G蛋白结合受体介导的血管收缩
Caroline Lozahic1, Helen Maddock1, Mark Wheatley1
1Research Centre for Health & Life Sciences, Coventry University, Alison Gingell Building, Priory Street, Coventry, CV1 5FB, UK.
Naunyn-Schmiedeberg's archives of pharmacology
|February 7, 2024
概括
德克索鲁比化疗通过内素B,血清素1B和血栓素A2的前列腺素受体增加了血管光滑肌肉细胞收缩. 了解这些G蛋白结合受体通路可能有助于减轻多克索鲁比诱导的血管毒性.
科学领域:
- 心血管药理学心血管药理学
- 癌症治疗方法 癌症治疗方法
- 分子生物学分子生物学
背景情况:
- doxorubicin (doxo) 是一种重要的化疗剂,但其使用受到心脏和血管毒性的限制.
- 血管光滑肌细胞 (VSMC) 功能障碍有助于Doxo诱导的心血管并发症.
研究的目的:
- 调查Doxo对G蛋白结合受体 (GPCR) 介导的小鼠动脉血管收缩的影响.
- 为了确定哪些特定的GPCR受到Doxo暴露的影响.
主要方法:
- 鼠的左前下垂动脉段被用0.5μM Doxo化24小时.
- 肌谱被用来评估由内甲素受体 (ETA,ETB),血清素5-HT1B和血栓素A2前列腺素 (TP) 受体介导的血管收缩反应.
- 选择性激动剂和抗剂被用来验证受体特异性.
主要成果:
- Doxo化显著增加了ETB,5-HT1B和TP GPCRs介导的VSMC血管收缩.
- 观察到ETB中介收缩的2.2倍增加 (S6c),5-HT1B中介收缩的2.0倍增加 (5-CT),TP中介收缩的1.3倍增加 (U46619).
结论:
- 德克索鲁比暴露会通过血管光滑肌中的特定GPCR (ETB,5-HT1B,TP) 增强血管收缩.
- 对细胞内GPCR信号通路的进一步研究是有必要的,以开发减轻Doxo诱导的血管毒性的策略.
相关概念视频
Antihypertensive Drugs: Vasodilators
525
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
525
Antihypertensive Drugs: Action of Calcium Channel Blockers
518
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
518
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
515
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
515
Adrenergic Receptors: β Subtype
1.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.7K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
734
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
734
G-Protein Gated Ion Channels
4.6K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.6K


